Dermal penetration enhancers and drug delivery systems involving same
Abstract
A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer, characterised in that the dermal penetration enhancer is a safe skin-tolerant ester sunscreen. A non-occlusive, percutaneous or transdermal drug delivery system which comprises: (i) an effective amount of at least one physiologically active agent or prodrug thereof; (ii) at least one non-volatile dermal penetration enhancer, and (iii) at least one volatile liquid; characterized in that the dermal penetration enhancer is adapted to transport the physiologically active agent across a dermal surface or mucosal membrane of an animal, including a human, when the volatile liquid evaporates, to form a reservoir or depot of a mixture comprising the penetration enhancer and the physiologically active agent or prodrug within said surface or membrane; and the dermal penetration enhancer is of low toxicity to, and is tolerated by, the dermal surface or mucosal membrane of the animal.
Term
5.5 yearsto projected expiry
Projected expiry 4 April 2032, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
69 members in 15 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| PN814496 | Australia | A | |
| 9700091 | Australia | W |
Members69
| Document | Office | Kind | |
|---|---|---|---|
| CA2244089A1 | Canada | A1 | |
| WO9729735A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1713497A | Australia | A | |
| EP0901368A1 | European Patent Office (EPO) | A1 | |
| AU706967B2 | Australia | B2 | |
| NZ330942A | New Zealand | A | |
| AU5258999A | Australia | A | |
| KR19990087057A | Republic of Korea | A | |
| HK1018884A1 | Hong Kong, China | A1 | |
| EP0901368A4 | European Patent Office (EPO) | A4 | |
| JP2000504697A | Japan | A | |
| US6299900B1 | United States of America | B1 | |
| US2002028235A1 | United States of America | A1 | |
| US2004009214A1 | United States of America | A1 | |
| US2004013620A1 | United States of America | A1 | |
| US2004013621A1 | United States of America | A1 | |
| US2004028625A1 | United States of America | A1 | |
| US2004028725A1 | United States of America | A1 | |
| US2004081684A1 | United States of America | A1 | |
| US2004096405A1 | United States of America | A1 | |
| US2004146469A1 | United States of America | A1 | |
| US6818226B2 | United States of America | B2 | |
| US6916486B2 | United States of America | B2 | |
| US6916487B2 | United States of America | B2 | |
| US6923983B2 | United States of America | B2 | |
| US6929801B2 | United States of America | B2 | |
| US6964777B2 | United States of America | B2 | |
| US6998138B2 | United States of America | B2 | |
| EP0901368B1 | European Patent Office (EPO) | B1 | |
| DE69735804D1 | Germany | D1 | |
| ATE324865T1 | Austria | T1 | |
| EP1674068A1 | European Patent Office (EPO) | A1 | |
| US7094422B2 | United States of America | B2 | |
| DK0901368T3 | Denmark | T3 | |
| PT901368E | Portugal | E | |
| HK1087355A1 | Hong Kong, China | A1 | |
| ES2262173T3 | Spain | T3 | |
| DE69735804T2 | Germany | T2 | |
| KR100528602B1 | Republic of Korea | B1 | |
| US2007071803A1 | United States of America | A1 | |
| EP1769785A1 | European Patent Office (EPO) | A1 | |
| US2007077288A1 | United States of America | A1 | |
| HK1101553A1 | Hong Kong, China | A1 | |
| JP2007326867A | Japan | A | |
| US2008131494A1 | United States of America | A1 | |
| US7387789B2 | United States of America | B2 | |
| US2008152597A1 | United States of America | A1 | |
| EP1674068B1 | European Patent Office (EPO) | B1 | |
| ATE410136T1 | Austria | T1 | |
| US7438203B2 | United States of America | B2 | |
| DE69739037D1 | Germany | D1 | |
| PT1674068E | Portugal | E | |
| JP4213211B2 | Japan | B2 | |
| DK1674068T3 | Denmark | T3 | |
| ES2314538T3 | Spain | T3 | |
| CA2244089C | Canada | C | |
| EP1769785B1 | European Patent Office (EPO) | B1 | |
| ATE472997T1 | Austria | T1 | |
| DE69739931D1 | Germany | D1 | |
| PT1769785E | Portugal | E | |
| DK1769785T3 | Denmark | T3 | |
| ES2348313T3 | Spain | T3 | |
| US8071075B2 | United States of America | B2 | |
| LU91971I2 | Luxembourg | I2 | |
| LU91972I2 | Luxembourg | I2 | |
| LU91973I2This record | Luxembourg | I2 | |
| DE122012000019I1 | Germany | I1 | |
| DE122012000020I1 | Germany | I1 | |
| DE122012000021I1 | Germany | I1 |
Numbers
- Application
- 91973
Titles2
- English
- Fentanyl
- French
- Fentanyl
Classification
- CPC, 35
- A61K8/046
- A61Q17/04
- A61K9/70
- A61K8/37
- A61K8/445
- A61K9/0014
- A61K9/12
- A61K9/122
- A61K47/14
- A61M35/003
- A61P1/08
- A61P11/00
- A61P11/06
- A61P13/08
- A61P15/10
- A61P15/16
- A61P15/18
- A61P17/10
- A61P17/14
- A61P25/04
- A61P25/06
- A61P25/20
- A61P25/22
- A61P29/00
- A61P31/22
- A61P33/06
- A61P35/00
- A61P39/00
- A61P5/24
- A61P5/26
- A61P5/30
- A61P7/02
- A61P9/12
- Y02A50/30
- A61K9/08
- IPC, 18
- A61K8 04
- A61K8 368
- A61K8 37
- A61K8 44
- A61K9 00
- A61K9 12
- A61K9 70
- A61K31 24
- A61K31 4178
- A61K31 4196
- A61K31 496
- A61K31 704
- A61K45 08
- A61K47 14
- A61L15 44
- A61M16 06
- A61M35 00
- A61Q17 04